Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

CHICAGO — Finerenone prevented new-onset atrial fibrillation or flutter in patients ... 95% CI, 2.2-3.5), a composite kidney outcome (aHR = 2; 95% CI, 1.4-2.7) and all-cause death (aHR = 4.3 ...

Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 ...

New research reveals subretinal drusenoid deposits as potential indicators of serious heart disease, highlighting the need ...

Related: This Heart Condition Is 3 Times More Common Than We Thought, Study Finds “I went to the Apple store to buy a new ...

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

For medically refractory vasovagal syncope (VVS) and functional bradycardia, the feasibility of off-label catheter cardioneuroablation (CNA) was supported by multicenter U.S. registry data.

New findings from multiple studies demonstrate that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of ...

Donald Trump again has raised the prospect of a new tariff on imported pharmaceuticals, reportedly pitched at a 25% rate.